Evidence map›Paper›PMID 32696951›Full record

ArticleGigaScience2020

A generalizable data-driven multicellular model of pancreatic ductal adenocarcinoma.

Boris Aguilar, David L Gibbs, David J Reiss, Mark McConnell, Samuel A Danziger, Andrew Dervan, Matthew Trotter, Douglas Bassett, Robert Hershberg, Alexander V Ratushny and 1 more

Open access · goldAbstract read
In one paragraph

Article in GigaScience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.6field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Phenotype control techniques for Boolean gene regulatory networks.bioRxiv : the preprint server for biology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Boris AguilarInstitute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA.
David L GibbsInstitute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA.
David J ReissBristol-Myers Squibb, 400 Dexter Avenue North, Suite 1200, Seattle, WA 98109, USA.
Mark McConnellBristol-Myers Squibb, 400 Dexter Avenue North, Suite 1200, Seattle, WA 98109, USA.
Samuel A DanzigerBristol-Myers Squibb, 400 Dexter Avenue North, Suite 1200, Seattle, WA 98109, USA.
Andrew DervanBristol-Myers Squibb, 400 Dexter Avenue North, Suite 1200, Seattle, WA 98109, USA.
Matthew TrotterBMS Center for Innovation and Translational Research Europe (CITRE), Pabellon de Italia, Calle Isaac Newton 4, Sevilla 41092, Spain.
Douglas BassettBristol-Myers Squibb, 400 Dexter Avenue North, Suite 1200, Seattle, WA 98109, USA.
Robert HershbergFormerly Celgene Corporation, 400 Dexter Avenue North, Suite 1200, Seattle, WA 98109, USA.
Alexander V RatushnyBristol-Myers Squibb, 400 Dexter Avenue North, Suite 1200, Seattle, WA 98109, USA.
Ilya ShmulevichInstitute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA.
Bristol-Myers Squibb (Germany) · DENorth Seattle College · USBristol-Myers Squibb (Switzerland) · CHCenter for Innovation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMechanistic models, when combined with pertinent data, can improve our knowledge regarding important molecular and cellular mechanisms found in cancer. These models make the prediction of tissue-level response to drug treatment possible, which can lead to new therapies and improved patient outcomes. Here we present a data-driven multiscale modeling framework to study molecular interactions between cancer, stromal, and immune cells found in the tumor microenvironment. We also develop methods to use molecular data available in The Cancer Genome Atlas to generate sample-specific models of cancer.

resultsBy combining published models of different cells relevant to pancreatic ductal adenocarcinoma (PDAC), we built an agent-based model of the multicellular pancreatic tumor microenvironment, formally describing cell type-specific molecular interactions and cytokine-mediated cell-cell communications. We used an ensemble-based modeling approach to systematically explore how variations in the tumor microenvironment affect the viability of cancer cells. The results suggest that the autocrine loop involving EGF signaling is a key interaction modulator between pancreatic cancer and stellate cells. EGF is also found to be associated with previously described subtypes of PDAC. Moreover, the model allows a systematic exploration of the effect of possible therapeutic perturbations; our simulations suggest that reducing bFGF secretion by stellate cells will have, on average, a positive impact on cancer apoptosis.

conclusionsThe developed framework allows model-driven hypotheses to be generated regarding therapeutically relevant PDAC states with potential molecular and cellular drivers indicating specific intervention strategies.

Indexed as

AlgorithmsDisease SusceptibilityModels, BiologicalAutocrine CommunicationCarcinoma, Pancreatic DuctalCell CommunicationCytokinesGene Expression Regulation, NeoplasticHumansOrgan SpecificityParacrine CommunicationPhenotypeCytokinescancer modelingdata-driven modelmulticellular modelpancreatic ductal adenocarcinoma

Identifiers

PMID32696951
PMCPMC7374045
OpenAlexW3044195376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.